Good pharma? Bad pharma? Better pharma.
作者信息
Hardman M
机构信息
M Hardman, AstraZeneca PLC Innovative Medicines and Early Development, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. Email
出版信息
J R Coll Physicians Edinb. 2014;44(4):269-72. doi: 10.4997/JRCPE.2014.403.
PMID:25516893
Abstract
摘要
相似文献
1
Good pharma? Bad pharma? Better pharma.好制药？坏制药？更好的制药。
J R Coll Physicians Edinb. 2014;44(4):269-72. doi: 10.4997/JRCPE.2014.403.
2
Report: FDA exerts too little oversight of researchers' conflicts of interest.报告：美国食品药品监督管理局对研究人员利益冲突的监督力度过小。
JAMA. 2009 Feb 18;301(7):709-10. doi: 10.1001/jama.2009.127.
3
FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.美国食品药品监督管理局发布临床试验利益冲突规则。美国食品药品监督管理局。
AIDS Treat News. 1998 Mar 6(No 290):8.
4
Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.代笔、数据操纵与金元外交：制药公司如何在临床研究中幕后操纵
Ann Emerg Med. 2008 Aug;52(2):137-9. doi: 10.1016/j.annemergmed.2008.06.009.
5
Conflicts of interest, institutional corruption, and pharma: an agenda for reform.利益冲突、机构腐败与制药业：改革议程。
J Law Med Ethics. 2012 Fall;40(3):511-22. doi: 10.1111/j.1748-720X.2012.00683.x.
6
Better regulation of industry-sponsored clinical trials is long overdue.早就应该对行业资助的临床试验进行更好的监管了。
J Law Med Ethics. 2009 Fall;37(3):410-9, 395. doi: 10.1111/j.1748-720X.2009.00402.x.
7
Physicians and clinical trials. To avoid federal scrutiny, take care when determining fair market value.
Mod Healthc. 2013 Sep 23;43(38):22.
8
NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.神经中枢：随着许多学术医疗中心进行自查，美国监察长办公室就国立卫生研究院对利益冲突监督不力发出警告。
Ann Neurol. 2010 Mar;67(3):A7-A10. doi: 10.1002/ana.22026.
9
Regulating the market in human research participants.规范人类研究参与者市场。
PLoS Med. 2006 Aug;3(8):e330. doi: 10.1371/journal.pmed.0030330.
10
Family physicians support Open Pharma.家庭医生支持开放制药。
CMAJ. 2017 Jul 10;189(27):E923. doi: 10.1503/cmaj.1095448.
Zotero 插件